How to buy Dechra Pharmaceuticals (DPH) shares

Learn how to easily invest in Dechra Pharmaceuticals shares.

Dechra Pharmaceuticals PLC (DPH) is a publicly traded drug manufacturers-general business based in the UK. In the week up to 26 September Dechra Pharmaceuticals shares plunged 10.51% to a closing position of 2640p. Over the last 12 months, Dechra Pharmaceuticals's share price has fallen by an alarming 47.27% from 4828p. Dechra Pharmaceuticals is listed on the London Stock Exchange (LSE) and employs 1,998 staff. All prices are listed in pence sterling.

How to buy shares in Dechra Pharmaceuticals

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: DPH in this case.
  5. Research Dechra Pharmaceuticals shares. The platform should provide the latest information available.
  6. Buy your Dechra Pharmaceuticals shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 10x Dechra Pharmaceuticals shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £0.00
£254.60 total
Capital at risk
IG Share Dealing logo £0 £250 £8.00
£262.60 total
Capital at risk
Fineco logo £0 No minimum £0.00
£254.60 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£266.55 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.79
£256.39 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£262.59 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£264.10 total
Capital at risk

Full comparison of share dealing platforms

Dechra Pharmaceuticals share price (LSE:DPH)

Use our graph to track the performance of DPH stocks over time.

Dechra Pharmaceuticals price performance over time

Historical closes compared with the last close of 2546p

1 week (2022-09-29) 0.87%
1 month (2022-09-06) -19.68%
3 months (2022-07-06) -31.78%
6 months (2022-04-05) -39.92%
1 year (2021-10-05) -47.27%
2 years (2020-10-06) -21.71%
3 years (2019-10-04) -6.94%
5 years (2017-10-05) 19.98%

Is it a good time to buy Dechra Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

IG bxs hero

Invest in Dechra Pharmaceuticals shares with IG

  • No commission on US shares
  • More than 13,000 shares to invest in
  • Open your account in minutes

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Dechra Pharmaceuticals under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Dechra Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 49x. In other words, Dechra Pharmaceuticals shares trade at around 49x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.


Dechra Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £139.2 million.

The EBITDA is a measure of a Dechra Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Dechra Pharmaceuticals shares at a glance

Information last updated 2022-10-05.
Previous close2630p
Change %-3.1939%
Information last updated 2022-10-02.
52-week range2512p - 5389.6304p
50-day moving average3322.5066p
200-day moving average3733.9048p
Wall St. target price4334p
PE ratio49.4717
Dividend yield44.9p (1.71%)
Earnings per share (TTM)0.53p

Dechra Pharmaceuticals share dividends


Dividend yield: 1.71% of stock value


Forward annual dividend yield: 1.71% of stock value

Dechra Pharmaceuticals has recently paid out dividends equivalent to 1.71% of its share value annually.

Dechra Pharmaceuticals has paid out, on average, around 140.15% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.71% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 1.71% return on their shares, in the form of dividend payments. In Dechra Pharmaceuticals's case, that would currently equate to about 44.9p per share.

Dechra Pharmaceuticals's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 27 October 2022 (the "ex-dividend date").

Share price volatility

Over the last 12 months, Dechra Pharmaceuticals's shares have ranged in value from as little as 2512p up to 5389.6304p. A popular way to gauge a stock's volatility is its "beta".

DPH.LSE volatility(beta: 0.61)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Dechra Pharmaceuticals's is 0.6141. This would suggest that Dechra Pharmaceuticals's shares are less volatile than average (for this exchange).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site